Background: endoscopic ultrasonography (EUS) and magnetic resonance cholangiography (MRC) are the elective tests in the diagnosis of choledocholithiasis. MRC is best accepted by patients, but its sensitivity might decrease in the evaluation of microlithiasis.Aim: to evaluate the diagnostic accuracy and therapeutic impact of EUS in a prospective cohort of patients with intermediate suspicion of choledocolithiasis and no findings in MRC (normal MRC).Material and methods: during a period of 24 months, all the patients with clinical intermediate suspicion of choledocholithiasis and normal MRC were included. Sensitivity, specificity, diagnostic accuracy, positive predictive value (PPV) and negative predictive value (NPV) of MRC and EUS were compared, and so their impact in the management of these patients.Results: seventy six patients were evaluated (lithiasis in 30% of them). Sensitivity and diagnostic accuracy of EUS (100%, 92%) were significantly higher than MRC values (0%, 70%) (p < 0.05). EUS findings (suspicion of choledocholithiasis) favored a significant change in therapeutic attitude (therapeutic ERCP was performed) in 38% of the patients (in which MRC had ruled out the presence of choledocholithiasis, and so, ERCP had not been performed) (p < 0.05).Conclusions: EUS allows the diagnosis of lithiasis in approximately 1/3 of patients with intermediate suspicion of choledocholithiasis and normal MRC. EUS findings involve a significant change in the management of these patients; this supports the use of EUS in clinical practice.Key words: Endoscopic ultrasonography. Magnetic resonance Cholangiography. Diagnostic accuracy. Therapeutic impact. Choledocholithiasis.
INTRODUCTIONCholelithiasis is a major gastrointestinal disease, and choledocholithiasis is one of its main complications (1). The prevalence of choledocholithiasis in patients who have undergone a previous cholecystecthomy due to symptomatic cholelithiasis, and in patients with acute biliary pancreatitis, is estimated in 5-10% and 18-33%, respectively (2). Diagnosis of choledocholithiasis is based on clinical signs and symptoms, serum markers of cholestasis and imaging tests -abdominal ultrasonography and even computed tomography (CT)-(3). Since the introduction of endoscopic retrograde cholangiography (ERCP), it has been considered the gold standard for the diagnosis and eventually the nonsurgical therapeutic approach for choledocolithiasis (4). However, because of the associated risks -pancreatitis (1,3-6,7%), infection (0,6-5%), hemorrhage (0,3-2%) and perforation (0,1-1,1%)-(5-7), at the present time, ERCP is almost exclusively reserved for therapeutic purpose (8,9), and it has been replaced by less invasive tests, such as magnetic resonance cholangiography (MRC) and endoscopic ultrasonography (EUS), for the diagnosis of choledocolithiasis.In order to establish the likelihood of choledocholithiasis, different algorithms have been developed considering clinical, analytical and radiological findings; these algorithms allow us to classify patients in hi...